MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
AZN — AstraZeneca PLC
NYSEAstraZeneca PLC
$156.90
-0.80(-0.51%)
- O
- 158.46
- H
- 158.80
- L
- 156.41
- V
- 2.64M
⏱️ End-of-day dataAs of Oct 2, 2026
Chart
About AZN
A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.
IndustryCommon Stock
SectorNot available
IPO DateOct 23, 2009
Employees96,100
Stock ExchangeNYSE
Ticker SymbolAZN
Websitehttps://www.astrazeneca.com
Key Financial Statistics
| Market Cap | $258.35B |
| P/E Ratio | N/A |
| Dividend Yield | 1.01% (Semi-Annual) |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $153.41 - $212.71 |
| 52-Week Avg Volume | 2.74M |
| VWAP | $157.12 |
| Transactions | 57,806 |
| Total Recorded Bars | 4,436 days |